Medicine and Dentistry
Patient
100%
Epstein Barr Virus
61%
Combination Therapy
42%
T-Helper Cell
40%
Germinal Center
34%
Neoplasm
28%
Infection
28%
B Cell
26%
Hazard Ratio
26%
Immune Response
25%
Memory B Cell
25%
Inpatient
23%
Gene
23%
Acute Lymphoblastic Leukemia
22%
Follicular Lymphoma
22%
T Cell
21%
Pathogenesis
20%
Infectious Arthritis
20%
Nilotinib
20%
Lung Cancer
20%
Vitamin D
20%
Regulatory T Cell
20%
Immunosuppressive Treatment
20%
Lymphoma Cell
20%
Epidermal Growth Factor Receptor
20%
Programmed Death-Ligand 1
20%
B Cell Leukemia
20%
Endocarditis
20%
Gefitinib
20%
Persistent Infection
20%
B-Cell Lymphoma
20%
Knee Arthroplasty
20%
Prosthetics
20%
Mucosa
20%
Malignant Neoplasm
20%
Epstein-Barr Virus
20%
Chromosome Aberration
20%
Hematopoietic Cell
20%
Cell Transplantation
20%
Virus
16%
Tissues
15%
Survival
14%
Diffuse Large B-Cell Lymphoma
14%
Exhaustion
12%
Odds Ratio
12%
Association
12%
Development
12%
Event Free Survival
12%
Lymphoma
11%
Therapeutic Procedure
11%
Biochemistry, Genetics and Molecular Biology
Gefitinib
61%
Mutation
42%
Apoptosis
22%
Cancer Cell
22%
Vitamin D
20%
Dilution
20%
Association
20%
Epidermal Growth Factor Receptor
12%
Prospective Cohort Study
10%
Overall Survival
10%
Event Free Survival
10%
Survival
10%
Age
10%
Somatic Mutation
5%
Mutant
5%
Sequencing
5%
Immunology and Microbiology
Epstein Barr Virus
40%
Memory B Cell
30%
Germinal Center
28%
B Cell
20%
Regulatory T Cell
20%
Cell Transplantation
20%
Mutation
20%
Immune Response
7%
Viral Disease
7%
Cell Shape
5%
Transplantation
5%